Multi-ancestry meta-analysis and fine-mapping in Alzheimer's disease

J Lake, C Warly Solsberg, JJ Kim, J Acosta-Uribe… - Molecular …, 2023 - nature.com
Genome-wide association studies (GWAS) of Alzheimer's disease are predominantly carried
out in European ancestry individuals despite the known variation in genetic architecture and …

SYF2 suppression mitigates neurodegeneration in models of diverse forms of ALS

GR Linares, Y Li, WH Chang, J Rubin-Sigler… - Cell Stem Cell, 2023 - cell.com
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease caused by many
diverse genetic etiologies. Although therapeutics that specifically target causal mutations …

Harnessing deep learning into hidden mutations of neurological disorders for therapeutic challenges

S Yang, SH Kim, M Kang, JY Joo - Archives of Pharmacal Research, 2023 - Springer
The relevant study of transcriptome-wide variations and neurological disorders in the
evolved field of genomic data science is on the rise. Deep learning has been highlighted …

The influence of 17q21.31 and APOE genetic ancestry on neurodegenerative disease risk

NV Harerimana, AM Goate, KR Bowles - Frontiers in Aging …, 2022 - frontiersin.org
Advances in genomic research over the last two decades have greatly enhanced our
knowledge concerning the genetic landscape and pathophysiological processes involved in …

Single-nucleus RNA sequencing demonstrates an autosomal dominant Alzheimer's disease profile and possible mechanisms of disease protection

MC Almeida, SJ Eger, C He, M Audouard, A Nikitina… - Neuron, 2024 - cell.com
Highly penetrant autosomal dominant Alzheimer's disease (ADAD) comprises a distinct
disease entity as compared to the far more prevalent form of AD in which common variants …

[HTML][HTML] Association of common and rare variants with Alzheimer's Disease in over 13,000 diverse individuals with whole-genome sequencing from the Alzheimer's …

WP Lee, SH Choi, MG Shea, PL Cheng, BA Dombroski… - medRxiv, 2023 - ncbi.nlm.nih.gov
Alzheimer's Disease (AD) is a common disorder of the elderly that is both highly heritable
and genetically heterogeneous. Here, we investigated the association between AD and both …

Frontotemporal dementia presentation in patients with heterozygous p. H157Y variant of TREM2

N Ogonowski, H Santamaria-Garcia, S Baez… - Journal of Medical …, 2023 - jmg.bmj.com
Background The triggering receptor expressed on myeloid cell 2 (TREM2) is a major
regulator of neuroinflammatory processes in neurodegeneration. To date, the p. H157Y …

Neurocognitive patterns across genetic levels in behavioral variant frontotemporal dementia: a multiple single cases study

H Santamaría-García, N Ogonowsky, S Baez… - BMC neurology, 2022 - Springer
Background Behavioral variant frontotemporal dementia (bvFTD) has been related to
different genetic factors. Identifying multimodal phenotypic heterogeneity triggered by …

Cholinergic-like neurons and cerebral spheroids bearing the PSEN1 p. Ile416Thr variant mirror Alzheimer's disease neuropathology

N Gomez-Sequeda, M Mendivil-Perez… - Scientific Reports, 2023 - nature.com
Familial Alzheimer's disease (FAD) is a complex neurodegenerative disorder for which there
are no therapeutics to date. Several mutations in presenilin 1 (PSEN 1), which is the catalytic …

Combination of Tramiprosate, Curcumin, and SP600125 Reduces the Neuropathological Phenotype in Familial Alzheimer Disease PSEN1 I416T Cholinergic-like …

N Gomez-Sequeda, M Jimenez-Del-Rio… - International Journal of …, 2024 - mdpi.com
Familial Alzheimer's disease (FAD) is a complex and multifactorial neurodegenerative
disorder for which no curative therapies are yet available. Indeed, no single medication or …